Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Zogenix
Biotech
3rd time's not the charm for Novartis as Shanker departs
Novartis' head of neuroscience joins exodus bandwagon to take chief scientific officer role at gene therapy startup Tevard Biosciences.
Kyle LaHucik
May 19, 2021 9:55am
After Dravet hiccup, Zogenix's Fintepla logs Lennox-Gastaut win
Feb 7, 2020 10:45am
Zogenix pays $250M upfront for startup Modis buyout
Aug 26, 2019 10:25am
Zogenix data blunder trips up FDA filing for epilepsy drug Fintepla
Apr 9, 2019 6:54am
Chasing GW, Zogenix scores a win in second Dravet phase 3
Jul 12, 2018 9:10am
